Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks-Reference-Cited by-同舟云学术

Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks

Published:2009-11 Issue:5 Volume:61 Page:793-798
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Sivanesan S. Priya,Gattu Shilpa,Hong Judith,Chavez-Frazier Arianne,Bandow Grace D.,Malick Farah,Kricorian Greg,Koo John

Publisher

Elsevier BV

Subject

Dermatology

Reference18 articles.

1. Photochemotherapy;Lauharanta;Clin Dermatol,1997

2. Calcipotriol in combination with PUVA: a randomized double blind placebo study in severe psoriasis;Frappaz;Eur J Dermatol,1993

3. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light;Parrish;N Engl J Med,1974

4. Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial;Melski;J Invest Dermatol,1977

5. Photochemotherapy for psoriasis with orally administered methoxsalen;Wolff;Arch Dermatol,1976

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of natural compounds for potential psoriasis treatment;Inflammopharmacology;2023-03-30

2. A deep dive into UV-based phototherapy: Mechanisms of action and emerging molecular targets in inflammation and cancer;Pharmacology & Therapeutics;2021-06

3. Psoralen Plus Ultraviolet A Photochemotherapy and Other Phototherapy Modalities;Comprehensive Dermatologic Drug Therapy;2021

4. Potential herbal constituents for psoriasis treatment as protective and effective therapy;Phytotherapy Research;2020-12-05

5. Topical Therapy II: Retinoids, Immunomuodulators, and Others/Ultraviolet Therapy for Psoriasis;Advances in Psoriasis;2020-11-27